MCUJFOTCPharmaceutical PreparationsFiscal year ends December 31
MEDICURE INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$3.10+0.12 (+4.07%)
Close on Oct 19, 2026
MEDICURE INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail and Mail Order Pharmacy [Member] | C$20.29M | C$10.83M | C$9.58M | C$7.78M | C$7.43M | C$340.00K | – | – | – | – | 70.3% | +87.3% |
| Marketing and Distribution of Commercial Products [Member] | C$8.57M | C$11.08M | C$12.12M | C$15.28M | C$14.32M | C$11.27M | – | – | – | – | 29.7% | -22.6% |
By product or service
By region
From the segment and revenue-disaggregation notes of Medicure's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.